603127 Joinn Laboratories
- 14.02
- +0.31+2.26%
Joinn Laboratories News
Zhaoyan Pharmaceutical: Beijing Zhaoyan New Drug Research Center Co., Ltd.'s 2021 A-share equity allocation implementation announcement
Zhaoyan Xinyao: Announcement on the progress of Zhaoyan Xinyao Pharmaceutical's acquisition of 100% of the shares of Guangxi Weimei Biotechnology Co., Ltd.
Zhaoyan New Drug: Beijing Zhaoyan New Drug Research Center Co., Ltd. 2021 Annual Profit Distribution and Provident Fund Transfer Plan Announcement
Zhaoyan New Pharmaceutical: Announcement on the Purchase of Wealth Management Products
Zhaoyan New Pharmaceutical: Announcement on the Purchase of Wealth Management Products
Zhaoyan New Pharmaceutical: Announcement on participation in the bid for 80% of the shares of Shanghai Slake Laboratory Animal Co., Ltd.
Zhaoyan Pharmaceutical: Announcement on the completion of the cash purchase of 100% of the shares of Biomere in the US
Zhaoyan Pharmaceutical: Announcement on the progress of the acquisition of 100% of the shares of Biomere in the US company Biomere in cash
Zhaoyan Pharmaceutical: Announcement on the progress of the acquisition of 100% of the shares of Biomere in the US company Biomere in cash
Zhaoyan Pharmaceutical: Announcement on the progress of the acquisition of 100% of the shares of Biomere in the US company Biomere in cash
Zhaoyan Pharmaceutical: Announcement on the progress of the acquisition of 100% of the shares of Biomere in the US company Biomere in cash
Zhaoyan Pharmaceutical: Announcement on the acquisition of 100% of the shares of Biomere in the US company Biomere in cash
Zhaoyan Pharmaceutical: Announcement on the purchase of financial products by the company and its wholly-owned subsidiaries
Zhaoyan New Pharmaceutical: Announcement on the Purchase of Wealth Management Products
Zhaoyan New Pharmaceutical: Announcement on the Purchase of Structured Deposit Products
Analysis
Price Target
No Data
